This webinar is recorded live and the sessions are available for delegates to access freely for six months once uploaded to our e-Learning platform. *Please note we endeavour to upload content as quickly as possible after each conference, but it typically takes 1-2 weeks.

Join us for this FREE live 90-minute webinar focusing on focusing on chronic kidney disease and diabetes.

Chronic kidney disease (CKD) (stages 3-5) affects 1 in 10 people globally. Of these, the cause is diabetes in 42%. In addition to impairment of quality of life, CKD is associated with approximately 45,000 premature deaths in the UK each year.

Standard treatment for CKD in patients is blood pressure control and use of ACE-inhibitors/ARBs – in addition to tight glycaemic control for those with diabetes. Until recently, there had been no significant therapeutic advance in the treatment of CKD for 20 years. Despite these treatment, significant residual risk for worsening CKD as well as cardiovascular morbidity and mortality for patients with CKD remain.

Newer treatment options for diabetes can provide renoprotection to reduce both progression of CKD and its closely linked cardiovascular risk.

Learning objectives

  1. Appreciate the implications of renal complications for morbidity and mortality within the cardiorenal-metabolic system.
  2. Examine evidence for existing and newer treatment options for renoprotection in patients with CKD and diabetes.
  3. Review progression of national and international guidance for management of CKD as medical evidence has progressed.
  4. Understand the role of targeted anti-glycaemic treatment for people with CKD.

There will be plenty of time in this webinar for Q&A

This webinar will be Chaired by Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info.

Webinar Speakers:

  • Dr Pauline Swift, Consultant Nephrologist, St Helier Hospital
  • Professor David Wheeler, Professor of Kidney Medicine at UCL, UK and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust
  • Professor Naveed Sattar, Professor and Honorary Consultant Cardiovascular & Medical Sciences